MARKET

AGYTF

AGYTF

Allergy Ther
OTCPK
0.110
NaN%
Closed 09:30 04/14 EDT
OPEN
--
PREV CLOSE
0.110
HIGH
--
LOW
--
VOLUME
--
TURNOVER
--
52 WEEK HIGH
0.159
52 WEEK LOW
0.110
MARKET CAP
696.58M
P/E (TTM)
-8.2707
1D
5D
1M
3M
1Y
5Y
1D
Allergy Therapeutics boosts funding as Grassmuno launch and peanut vaccine advance
TipRanks · 03/31 07:12
Allergy Therapeutics Reshapes Major Shareholding Ahead of Potential Hong Kong Listing
TipRanks · 03/12 07:10
Allergy Therapeutics’ VLP Peanut Shows Strong Immune Response in Early-Stage Trial
TipRanks · 03/04 07:18
Allergy Therapeutics showcases new allergy immunotherapy data at AAAAI 2026
TipRanks · 02/26 07:22
Allergy Therapeutics seals £40m Hayfin facility and simplifies capital structure
TipRanks · 02/23 07:58
Allergy Therapeutics Bolsters Board and Strategy Team to Drive Global Expansion
TipRanks · 01/30 08:53
Allergy Therapeutics Wins Strong Shareholder Backing at 2026 AGM
TipRanks · 01/29 14:37
Allergy Therapeutics Grants Performance-Linked Share Options to Senior Management
TipRanks · 01/28 16:52
More
About AGYTF
Allergy Therapeutics plc is a United Kingdom-based international commercial biotechnology company. The Company is focused on the treatment and diagnosis of allergic disorders, including aluminum free immunotherapies that have the potential to cure disease. It sells proprietary and third-party products from its subsidiaries in nine European countries and via distribution agreements in an additional 10 countries. It sells both injectable and sublingual (oral) allergen-specific immunotherapies. Its pipeline of products in clinical development includes vaccines for grass, tree, house dust mite and peanut. Its therapies are traded under various brand names depending on the market, such as Pollinex Quattro, Polligoid and TA Graser Top. Its commercial products include Pollinex Quattro, Oralvac, Venomil, Venom ATL Polistes Dominula, Synbiotics and Acarovac Plus. Its pipeline candidates include Grass MATA MPL, Birch MATA MPL, Ragweed MATA MPL, Trees MATA MPL, and VLP Peanut.

Webull offers Allergy Therapeutics plc stock information, including OTCPK: AGYTF real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, AGYTF stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading AGYTF stock methods without spending real money on the virtual paper trading platform.